## 1. Experimental Purpose
**Scientific Question Formulation:**
- **Problem specificity:** Define whether you're addressing a classification problem (e.g., mutation pathogenicity), regression problem (e.g., expression level prediction), clustering task (e.g., cell type identification), or generative challenge (e.g., protein structure prediction)
- **Data-to-question alignment:** Ensure your data type (genomic, transcriptomic, proteomic, clinical) directly informs your question
- **Hypothesis granularity:** Formulate testable computational hypotheses at multiple levels (molecular, cellular, tissue, organism)
- **Prediction scope:** Determine whether your method aims for mechanistic insight, diagnostic application, therapeutic guidance, or prognostic value

**Iterative Development Strategy:**
- **Benchmark selection:** Choose appropriate existing methods to compare against (e.g., SIFT vs. PolyPhen for variant prediction)
- **Performance metrics prioritization:** Decide which metrics matter most (accuracy, precision, recall, F1, AUROC, AUPRC) based on downstream applications
- **Transfer learning approach:** Determine whether to train from scratch or leverage pre-trained models (e.g., protein language models like ESM-2)
- **Ablation study design:** Plan systematic removal of features/components to assess their contribution

## 2. Model System Selection

**Data Source Considerations:**
- **Primary data sources:**
  - Human clinical data (direct relevance but limited control)
  - Patient-derived organoids (3D structure with patient genetics)
  - Primary cell cultures (patient-specific but limited lifespan)
  - Established cell lines (reproducible but potentially divergent)
  - Model organisms (genetic manipulation but evolutionary distance)
  - Synthetic data (complete control but potential artificiality)

- **Multi-omics integration:** Determine whether to use single-modality or multi-modal data (genomic + transcriptomic + proteomic + clinical)
- **Temporal dimension:** Consider static vs. time-series data based on biological dynamics
- **Spatial resolution:** Evaluate bulk vs. single-cell vs. spatial transcriptomics/proteomics approaches

**Alternative Data Sources Assessment:**
- **Public database selection:** Choose between repositories (GEO, TCGA, GTEx, UK Biobank) based on sample size, annotation quality, and population diversity
- **Synthetic data generation:** Consider GANs or VAEs to augment limited datasets or address privacy concerns
- **Simulated data application:** Evaluate when to use simulated data (e.g., for testing extreme conditions)

**Ethical Framework Implementation:**
- **Consent granularity:** Ensure data usage aligns with original consent parameters
- **Bias detection protocol:** Implement methods to identify and quantify dataset biases
- **Fairness metrics:** Select appropriate fairness measures (demographic parity, equal opportunity, equalized odds)
- **Interpretability requirements:** Balance performance with explainability based on application context

## 3. Measurement Approach

**Methodological Selection:**
- **Algorithm taxonomy:**
  - **Classical machine learning:**
    - Linear methods (Logistic regression, SVM, elastic net)
    - Tree-based methods (Random Forest, XGBoost, LightGBM)
    - Probabilistic models (Bayesian networks, Hidden Markov Models)
    - Kernel methods (kernel SVM, Gaussian processes)
  
  - **Deep learning architectures:**
    - Convolutional networks (for image or k-mer data)
    - Recurrent networks (LSTM/GRU for sequential data)
    - Transformer models (for capturing long-range dependencies)
    - Graph neural networks (for interaction networks)
    - Variational autoencoders (for dimensionality reduction)
    - Generative adversarial networks (for synthetic data)
    - Hybrid architectures (CNN-LSTM, CNN-Transformer)

- **Feature engineering strategies:**
  - Manual feature selection based on domain knowledge
  - Automated feature selection (LASSO, recursive feature elimination)
  - Feature embedding (word2vec, doc2vec for biological sequences)
  - Dimensionality reduction (PCA, t-SNE, UMAP)

- **Hyperparameter optimization:**
  - Grid search vs. random search vs. Bayesian optimization
  - Learning rate scheduling (step, cosine, one-cycle)
  - Regularization approach (L1, L2, dropout, batch normalization)

**Validation Strategy Implementation:**
- **Cross-validation design:**
  - k-fold vs. stratified k-fold vs. leave-one-out
  - Nested cross-validation for hyperparameter tuning
  - Patient-wise vs. sample-wise partitioning
  - Temporal validation for time-series data

- **Ensemble methodology:**
  - Bagging vs. boosting vs. stacking
  - Model averaging vs. weighted averaging
  - Diversity promotion in ensemble members
  - Heterogeneous vs. homogeneous ensembles

**Bias Mitigation Techniques:**
- **Data-level interventions:**
  - Resampling techniques (SMOTE, ADASYN, Tomek links)
  - Synthetic data augmentation (noise addition, SMOTE variants)
  - Batch effect correction (ComBat, Harmony, Seurat integration)
  - Missing data imputation (KNN, MICE, matrix factorization)

- **Algorithm-level approaches:**
  - Cost-sensitive learning with class weights
  - Focal loss for imbalanced classification
  - Adversarial debiasing during training
  - Fairness constraints as regularization terms

## 4. Group Setting Design

**Experimental Groups Structuring:**
- **Data partitioning strategy:**
  - Random vs. stratified vs. temporal splits
  - Hold-out validation set size (10%, 20%, 30%)
  - External validation cohort selection criteria
  - Cross-study validation approach

- **Confounding variable control:**
  - Matching algorithms (propensity score, coarsened exact matching)
  - Covariate adjustment in model training
  - Residualization of unwanted variation
  - Causal inference frameworks (potential outcomes, causal graphs)

**Control Implementation Strategy:**
- **Negative controls:**
  - Permutation testing with shuffled labels
  - Comparison to theoretical null distributions
  - Use of known non-functional variants/sequences
  - Scrambled or reversed biological sequences

- **Computational baselines:**
  - Simple heuristic models (GC content, sequence length)
  - Published algorithms as performance floors
  - State-of-the-art methods as performance ceilings
  - Ensemble of existing methods

**Replication Strategy Design:**
- **Internal validation:**
  - Bootstrap resampling with confidence intervals
  - Jackknife resampling for influence analysis
  - Monte Carlo cross-validation
  - Out-of-bag estimates for ensemble methods

- **External validation:**
  - Independent dataset testing protocol
  - Cross-platform validation approach
  - Cross-species validation where applicable
  - Prospective validation planning

**Experimental Extensions Planning:**
- **Ablation studies:**
  - Feature importance quantification (SHAP, LIME)
  - Layer-wise relevance propagation for deep networks
  - Knockout studies of network components
  - Gradient-based attribution methods

- **Sensitivity analysis:**
  - Hyperparameter perturbation tests
  - Training data subsampling curves
  - Noise addition robustness testing
  - Adversarial example generation

## 5. Data Analysis & Presentation

**Data Processing Pipeline:**
- **Preprocessing protocols:**
  - Normalization methods (min-max, z-score, quantile, TPM, RPKM)
  - Outlier detection and handling (IQR, z-score, isolation forest)
  - Quality control metrics and thresholds
  - Batch correction algorithms (ComBat, RUV, scVI)

- **Feature transformation:**
  - Log transformation for skewed distributions
  - Power transformations (Box-Cox, Yeo-Johnson)
  - Rank-based inverse normal transformation
  - Non-linear embeddings (UMAP, t-SNE, autoencoders)

**Statistical Analysis Framework:**
- **Hypothesis testing selection:**
  - Parametric tests (t-test, ANOVA, linear regression)
  - Non-parametric alternatives (Mann-Whitney, Kruskal-Wallis)
  - Permutation-based significance testing
  - Bootstrapped confidence intervals

- **Multiple testing correction:**
  - Bonferroni vs. Benjamini-Hochberg vs. q-value
  - Family-wise error rate vs. false discovery rate
  - Adaptive procedures for correlation structure
  - Local FDR estimation methods

- **Effect size quantification:**
  - Cohen's d vs. odds ratio vs. hazard ratio
  - Confidence interval calculation methods
  - Minimal clinically important difference threshold
  - Number needed to treat/test calculations

**Visualization Standards Implementation:**
- **Plot selection by data type:**
  - Categorical data: Bar plots, mosaic plots, heatmaps
  - Continuous data: Box plots, violin plots, density plots
  - Relational data: Scatter plots, bubble plots, contour plots
  - Temporal data: Line plots, area charts, horizon plots
  - High-dimensional data: PCA plots, t-SNE, UMAP, heatmaps

- **Visualization best practices:**
  - Perceptually uniform color scales (viridis, cividis)
  - Colorblind-friendly palettes with sufficient contrast
  - Consistent scales across comparison figures
  - Appropriate error representation (SE, SD, CI, IQR)
  - Jittered points to show data distribution

**Validation Approach Selection:**
- **In silico validation:**
  - Simulated data with known ground truth
  - Cross-species conservation analysis
  - Structure-based validation for protein effects
  - Literature-derived knowledge bases

- **Experimental validation:**
  - Functional assays (reporter assays, CRISPR screens)
  - Orthogonal measurement technologies
  - Independent cohort replication
  - Prospective clinical validation

- **Deployment validation:**
  - A/B testing in clinical decision support
  - User feedback integration
  - Monitoring for performance drift
  - Continuous retraining protocols

By implementing this detailed framework, researchers can develop robust computational methods in biomedicine that maximize scientific validity, technical performance, and translational impact while minimizing bias and ensuring reproducibility.